Literature DB >> 19255847

Successful use of octreotide to treat Ménétrier's disease: a rare cause of abdominal pain, weight loss, edema, and hypoalbuminemia.

Michael Rothenberg1, Reetesh Pai, Kevin Stuart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19255847     DOI： 10.1007/s10620-009-0754-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  13 in total

1.  Treatment of Ménétrier's disease with a monoclonal antibody against the epidermal growth factor receptor.

Authors:  J S Burdick; E Chung; G Tanner; M Sun; J E Paciga; J Q Cheng; K Washington; J R Goldenring; R J Coffey
Journal:  N Engl J Med       Date:  2000-12-07       Impact factor: 91.245

2.  Menetrier's disease treated with octreotide long-acting release.

Authors:  Bryan T Green; M Stanley Branch
Journal:  Gastrointest Endosc       Date:  2004-12       Impact factor: 9.427

Review 3.  Ménétrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach.

Authors:  Robert J Coffey; Mary Kay Washington; Christopher L Corless; Michael C Heinrich
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

4.  Menetrier's disease: an excellent response to octreotide. A case report from the Middle East.

Authors:  Mohammed Osman El-Hassan Gadour; Ali Hassan Salman; El Tayeb El Wasela El Samman; Nabil Michael Tadros
Journal:  Trop Gastroenterol       Date:  2005 Jul-Sep

5.  Chronic treatment of Ménétrier's disease with Erbitux: clinical efficacy and insight into pathophysiology.

Authors:  Stephen H Settle; Kay Washington; Christopher Lind; Scott Itzkowitz; W Haley Fiske; J Steven Burdick; W Gray Jerome; Margaret Ray; Wilfred Weinstein; Robert J Coffey
Journal:  Clin Gastroenterol Hepatol       Date:  2005-07       Impact factor: 11.382

6.  Somatostatin analog RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostate cancer line in nude mice.

Authors:  J Pinski; G Halmos; A V Schally
Journal:  Cancer Lett       Date:  1993-07-30       Impact factor: 8.679

7.  Hypertrophic gastropathy resembling Ménétrier's disease in transgenic mice overexpressing transforming growth factor alpha in the stomach.

Authors:  H Takagi; C Jhappan; R Sharp; G Merlino
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

8.  EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-alpha-induced pulmonary fibrosis.

Authors:  William D Hardie; Cynthia Davidson; Machiko Ikegami; George D Leikauf; Timothy D Le Cras; Adrienne Prestridge; Jeffrey A Whitsett; Thomas R Korfhagen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-04-18       Impact factor: 5.464

9.  Possible role of transforming growth factor alpha in the pathogenesis of Ménétrier's disease: supportive evidence form humans and transgenic mice.

Authors:  P J Dempsey; J R Goldenring; C J Soroka; I M Modlin; R W McClure; C D Lind; D A Ahlquist; M R Pittelkow; D C Lee; E P Sandgren
Journal:  Gastroenterology       Date:  1992-12       Impact factor: 22.682

10.  Octreotide reduces enteral protein losses in Ménétrier's disease.

Authors:  P Yeaton; H F Frierson
Journal:  Am J Gastroenterol       Date:  1993-01       Impact factor: 10.864
View more
  9 in total

1.  Distinguishing Ménétrier's disease from its mimics.

Authors:  Amy Rich; Tania Zuluaga Toro; Jarred Tanksley; William H Fiske; Christopher D Lind; Gregory D Ayers; Hubert Piessevaux; Mary K Washington; Robert J Coffey
Journal:  Gut       Date:  2010-10-06       Impact factor: 23.059

2.  A pediatric non-protein losing Menetrier's disease successfully treated with octreotide long acting release.

Authors:  Giovanni Di Nardo; Salvatore Oliva; Marina Aloi; Federica Ferrari; Simone Frediani; Adriana Marcheggiano; Salvatore Cucchiara
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

3.  A case of Ménétrier's disease localized to the gastric antrum without helicobacter infection or hypoalbuminemia.

Authors:  Adam R Sweeney; Maureen K Lynch
Journal:  Int J Surg Case Rep       Date:  2013-07-17

4.  Natural history of adult-onset Ménétrier's disease: Report of a case with 9-year follow-up.

Authors:  Li-Shou Xiong; Ying-Ying Gong
Journal:  Exp Ther Med       Date:  2016-03-23       Impact factor: 2.447

5.  Robot-assisted laparoscopic gastrectomy for Menetrier's disease.

Authors:  Omaira Rodríguez Gonzalez; Rosciano José; Jara Génesis; Medina Luis; Vegas Liumariel; Ferrnandez Raquel; Sánchez Alexis
Journal:  J Robot Surg       Date:  2015-05-10

6.  A case of cytomegalovirus-negative Ménétrier's disease with eosinophilia in a child.

Authors:  Keun Hyung Son; Jeong Ja Kwak; Jae Ock Park
Journal:  Korean J Pediatr       Date:  2012-08-23

7.  Drug management of visceral pain: concepts from basic research.

Authors:  Mellar P Davis
Journal:  Pain Res Treat       Date:  2012-04-24

8.  Role of Octreotide in Menetrier's Disease: Case Report and Review of Literature.

Authors:  Aadil Khan; Anuj Chhaparia; Muhammad B Hammami; Christine Hachem
Journal:  Cureus       Date:  2020-11-16

9.  Total gastrectomy for the treatment of Menetrier's disease persistent to medical therapy: A case report.

Authors:  Christos Parianos; Chrysanthi Aggeli; Antigoni Sourla; Georgios Nikolaos Zografos
Journal:  Int J Surg Case Rep       Date:  2020-06-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.